The Washington State Health Care Authority Health Technology Clinical Committee (HTCC) reviewed balloon angioplasty and stenting for lower extremity peripheral artery disease evidence Nov. 21. ACR® participated in the discussion along with the Society of Interventional Radiology, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, and the Outpatient Endovascular and Interventional Society. ACR began monitoring this topic in August 2025.
HTCC issued draft findings and a coverage decision that are open for public comment until Dec. 16. The coverage determination is for Endovascular therapy for activity-limiting intermittent claudication and chronic limb-threatening ischemia as a covered benefit with conditions. ACR members who perform these procedures are encouraged to submit feedback. Email comments to shtap@hca.wa.gov.
Final findings and coverage decisions will be published in March. Meeting materials and presentations are on the HTCC website.
For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
ACR Releases Summary of MedPAC March Report
Highlighting MedPACās March findings on Medicare spending, payment adequacy, and key recommendations for physicians and hospitals.
Read moreState AI Healthcare Bills Draw ACR Attention
State legislatures are advancing AI healthcare bills targeting insurer denials, clinical guardrails, and transparency for AI use in care and coverage.
Read moreACR Backs Fix to Burdensome Noridian TPE Reviews
ACR urges Noridian to end prepayment reviews of radiologistsā professional components, citing access barriers and high denial rates.
Read more